NOVARTIS PHARMACEUTICALS CORPORATION
Patent Owner
Stats
- 79 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 21, 2017 most recent publication
Details
- 79 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,164 Total Citation Count
- Jun 24, 1981 Earliest Filing
- 64 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0324,821 COMPOUNDS CONTAINING S-N-VALERYL-N--VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONSJun 21, 16Nov 10, 16[A61K, C07D, C07C]
2010/0267,786 DUAL ACTING PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NE UTRAL ENDOPEPTIDASE (EP) INHIBITORNov 04, 08Oct 21, 10[A61K, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9598712 Chemical process for preparing spiroindolones and intermediates thereofMar 22, 13Mar 21, 17[C12P, C07D, C12N]
9187405 S1P receptor modulators for treating relasping-remitting multiple sclerosisApr 21, 14Nov 17, 15[A61K, C07C]
8877938 Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNov 08, 06Nov 04, 14[A61K, C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0005,324 Famciclovir for the Treatment of Recurrent Herpes Labialis Using a One-Day TreatmentAbandonedApr 14, 14Jan 01, 15[A61K]
2014/0113,919 COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASMAbandonedJun 13, 12Apr 24, 14[A61K]
8435563 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the sameWithdrawnJan 03, 12May 07, 13[A61K, A61P]
8106081 Combination of organic compounds useful for treating diabetesExpiredFeb 15, 10Jan 31, 12[A61K]
7943647 Process for the preparation of tetrazole derivatives from organo aluminium azidesExpiredJul 15, 04May 17, 11[A61K]
2011/0092,458 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral DiseasesAbandonedDec 22, 10Apr 21, 11[A61K, A61P]
2011/0028,526 VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONSAbandonedFeb 27, 09Feb 03, 11[A61K, A61P]
2010/0323,952 Nucleoside Analogs in Combination Therapy of Herpes Simplex InfectionsAbandonedAug 30, 10Dec 23, 10[A61K]
2010/0303,906 SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING SAMEAbandonedAug 09, 10Dec 02, 10[A61K, B05D, A61P]
2010/0233,253 EXTENDED RELEASE GASTRO-RETENTIVE ORAL DRUG DELIVERY SYSTEM FOR VALSARTANAbandonedAug 29, 07Sep 16, 10[A61K, A61P]
2010/0152,458 COUPLING REACTIONS USEFUL IN THE PREPARATION OF (1H-TETRAZOL-5-YL) BIPHENYL DERIVATIVESAbandonedMar 02, 10Jun 17, 10[C07D]
7728024 Metal salts of 2′-(1H-Tetrazol-5yl)-1.1′-biphenyl-4-carboxaldehydeExpiredJul 10, 06Jun 01, 10[A61K, C07D]
7700784 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivativesExpiredFeb 01, 05Apr 20, 10[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.